ADV-101

N/A

Report date: 2025/02/08 14:19:42

First In Class

Base Information

Drug NameADV-101

Drug Alias NameADV101ADV-101

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker

Mechanisms of ActionAnti-Interleukin-1 receptor accessory proteinDNA topoisomerase I inhibitors

TargetsInterleukin-1 receptor accessory proteinDNA topoisomerase I

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAdvesya SAS

China Registration ClassN/A

Develop Information

Active CompaniesAdvesya SAS

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A